By |

Profile

Adocia is a clinical-stage biotechnology company. It specializes in the development of formulations of already approved therapeutic proteins. The firm has developed Biochaperone proprietary technological platform to enhance the effectiveness of therapeutic proteins. The company's product pipeline includes biochaprone lispro, biochaparone combo, biochaparone human glucagon etc. Its patent portfolio mainly consists of chronic wound healing, insulin therapy, and monoclonal antibodies.

Contact Information

Website: www.adocia.com
Main Phone: +33 472610610
Address: 115 avenue Lacassagne
City / Town: Lyon
Country: FR
Postal Code: 69003

Issuer Information

Exchange: GREY
Employees: 132
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Adocia is a clinical-stage biotechnology company. It specializes in the development of formulations of already approved therapeutic proteins. The firm has developed Biochaperone proprietary technological platform to enhance the effectiveness of therapeutic proteins. The company's product pipeline includes biochaprone lispro, biochaparone combo, biochaparone human glucagon etc. Its patent portfolio mainly consists of chronic wound healing, insulin therapy, and monoclonal antibodies.

Contact Information

Website: www.adocia.com
Main Phone: +33 472610610
Address: 115 avenue Lacassagne
City / Town: Lyon
Country: FR
Postal Code: 69003

Issuer Information

Exchange: GREY
Employees: 132
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 17.00 $ 0. (0.00%)
Last Price 17.00 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 17.00
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap 117.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 6,937,701.00 EPS (TTM) 1.15 PE Ratio N/A Exchange Greys